https://www.taxtmi.com/notifications?id=16727 Exemption is granted from excise duty on patent or proprietary medicaments under Heading No. 30.03 to the extent the duty exceeds the rates specified. All formulations based on bulk drugs listed in the First Schedule to the Drugs (Prices Control) Order, 1987 (excluding tetracycline, hydrocortisone and ophthalmological use) attract a nil effective rate; single ingredient formulations based on bulk drugs in the Second Schedule attract the ad valorem rate specified. Definitions of "formulations," "single ingredient formulations" and "bulk drug" are provided consistent with the Drugs (Prices Control) Order, 1987 and the Drugs and Cosmetics Act, 1940. en-us Tue, 01 Mar 1988 00:00:00 +0530 Sat, 05 Sep 2009 09:29:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/notifications?id=16727 Exemption is granted from excise duty on patent or proprietary medicaments under Heading No. 30.03 to the extent the duty exceeds the rates specified. All formulations based on bulk drugs listed in the First Schedule to the Drugs (Prices Control) Order, 1987 (excluding tetracycline, hydrocortisone and ophthalmological use) attract a nil effective rate; single ingredient formulations based on bulk drugs in the Second Schedule attract the ad valorem rate specified. Definitions of "formulations," "single ingredient formulations" and "bulk drug" are provided consistent with the Drugs (Prices Control) Order, 1987 and the Drugs and Cosmetics Act, 1940. Notifications Central Excise Tue, 01 Mar 1988 00:00:00 +0530 https://www.taxtmi.com/notifications?id=16727